Literature DB >> 29359464

A prospective analysis for prevalence of complications in Thai nontransfusion-dependent Hb E/β-thalassemia and α-thalassemia (Hb H disease).

Supachai Ekwattanakit1, Noppadol Siritanaratkul1, Vip Viprakasit2,3.   

Abstract

Recently, complications in patients with nontransfusion-dependent thalassemia (NTDT), in particular those with β-thalassemia intermedia (β-TI), were found to be significantly different from those in patients with transfusion dependent thalassemia (TDT), mainly β-thalassemia major (β-TM). However, this information is rather limited in other forms of NTDT. In this prospective study, adult Thai NTDT patients were interviewed and clinically evaluated for thalassemia related complications. Fifty-seven NTDT patients (age 18-74 years), 59.6% Hb E/β-thalassemia and 40.4% Hb H disease, were recruited; 26.4% were splenectomized. The most common complications were gallstones (68.4%), osteoporosis (26.3%), and pulmonary hypertension (15.8%). Splenectomy was associated with higher rate of gallstones and serious infection (P = .001 and .052, respectively), consistent with a multivariate analysis (RR = 9.5, P = .044, and RR = 15.1, P = .043, respectively). In addition, a higher hemoglobin level was inversely associated with gallstones in both univariate and multivariate analyses (P = .01 and .022, respectively). Serum ferritin was associated with abnormal liver function (P = .002). In contrast to the previous study, the prevalence of thrombosis was less common in our population (1.7%), probably due to differences in transfusion therapy, ethnicity, and underlying genotypes. For the first time, this prospective study provided the current prevalence of NTDT related complications in a Southeast Asian population with a different underlying genetic basis compared with previous studies. Although individual prevalence of each complication might differ from other studies, several important clinical factors such as splenectomy, degree of anemia, and iron overload seem to be determining risks of developing these complications consistently across different ethnicities.
© 2018 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29359464     DOI: 10.1002/ajh.25046

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  7 in total

Review 1.  Leg Ulcers: A Report in Patients with Hemoglobin E Beta Thalassemia and Review of the Literature in Severe Beta Thalassemia.

Authors:  Vikita Mehta; Abirami Kirubarajan; Amir Sabouhanian; Sanasi M Jayawardena; Priya Chandrakumaran; Nila Thangavelu; Refai Cader; Sachith Mettananda; Dayananda Bandara; Shawn Khan; David J Weatherall; Angela Allen; Anuja P Premawardhena; Nancy F Olivieri
Journal:  Acta Haematol       Date:  2021-11-09       Impact factor: 3.068

2.  Epidemiology of thalassemia among the hill tribe population in Thailand.

Authors:  Tawatchai Apidechkul; Fartima Yeemard; Chalitar Chomchoei; Panupong Upala; Ratipark Tamornpark
Journal:  PLoS One       Date:  2021-02-11       Impact factor: 3.240

3.  Moderate to severe liver siderosis and raised AST are independent risk factors for vitamin D insufficiency in β-thalassemia patients.

Authors:  Hadi Darvishi-Khezri; Hossein Karami; Mohammad Naderisorki; Mohammad Zahedi; Alireza Razavi; Mehrnoush Kosaryan; Aily Aliasgharian
Journal:  Sci Rep       Date:  2020-12-03       Impact factor: 4.379

4.  Survival and complications in patients with haemoglobin E thalassaemia in Sri Lanka: a prospective, longitudinal cohort study.

Authors:  Anuja P Premawardhena; Dileepa Senajith Ediriweera; Amir Sabouhanian; Angela Allen; David Rees; Shanthimala de Silva; Windsor Perera; Nimal Katugaha; Mahinda Arambepola; Robert C Yamashita; Sachith Mettananda; Nilam Jiffry; Vikita Mehta; Refai Cader; Dayananda Bandara; Timothy St Pierre; Giulia Muraca; Christopher Fisher; Abirami Kirubarajan; Shawn Khan; Stephen Allen; Sanath P Lamabadusuriya; David J Weatherall; Nancy F Olivieri
Journal:  Lancet Glob Health       Date:  2021-11-26       Impact factor: 38.927

5.  An urgent need for improving thalassemia care due to the wide gap in current real-life practice and clinical practice guidelines.

Authors:  Supachai Ekwattanakit; Chattree Hantaweepant; Archrob Khuhapinant; Noppadol Siritanaratkul; Vip Viprakasit
Journal:  Sci Rep       Date:  2021-06-24       Impact factor: 4.379

6.  The relationships between pancreatic T2* values and pancreatic iron loading with cardiac dysfunctions,  hepatic and cardiac iron siderosis among Egyptian children and young adults with β-thalassaemia major and sickle cell disease: a cross-sectional study.

Authors:  Khaled Salama; Amina Abdelsalam; Hadeel Seif Eldin; Eman Youness; Yasmeen Selim; Christine Salama; Gehad Hassanein; Mohamed Samir; Hanan Zekri
Journal:  F1000Res       Date:  2020-09-09

7.  Iron overload status in patients with non-transfusion-dependent thalassemia in China.

Authors:  Yumei Huang; Gaohui Yang; Man Wang; Xiaoyun Wei; Lingyuan Pan; Jiaodi Liu; Yu Lei; Liling Long; Yongrong Lai; Rongrong Liu
Journal:  Ther Adv Hematol       Date:  2022-03-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.